webinar register page

Webinar banner
The Potential Life Sciences Implications of the Election
The medtech industry has significantly changed during the Trump administration’s last four years. FDA processes are streamlined, the medical device excise tax repealed, and the Senate is in the process of confirming a third Supreme Court nominee The industry also rapidly responded to the unprecedented Covid-19 health crisis.

What changes are on the horizon for the medtech industry after the November 3rd election, whether with another Trump administration or a Biden administration? In this session, attorney Jeffrey K. Shapiro of Hyman, Phelps & McNamara will cover the upcoming U.S. presidential election and its possible ramifications for the medical device industry.

Oct 28, 2020 02:00 PM in Eastern Time (US and Canada)

Webinar logo
* Required information

By registering, I agree to the Privacy Statement and Terms of Service.